The Complex Interplay Between Depression/Anxiety and Executive Functioning: Insights From the ECAS in a Large ALS Population
- PMID: 29674987
- PMCID: PMC5895754
- DOI: 10.3389/fpsyg.2018.00450
The Complex Interplay Between Depression/Anxiety and Executive Functioning: Insights From the ECAS in a Large ALS Population
Abstract
Introduction: The observed association between depressive symptoms and cognitive performances has not been previously clarified in patients with amyotrophic lateral sclerosis (pALS). In fact, the use of cognitive measures often not accommodating for motor disability has led to heterogeneous and not conclusive findings about this issue. The aim of the present study was to evaluate the relationship between cognitive and depressive/anxiety symptoms by means of the recently developed Edinburgh Cognitive and Behavioral ALS Screen (ECAS), a brief assessment specifically designed for pALS. Methods: Sample included 168 pALS (114 males, 54 females); they were administered two standard cognitive screening tools (FAB; MoCA) and the ECAS, assessing different cognitive domains, including ALS-specific (executive functions, verbal fluency, and language tests) and ALS non-specific subtests (memory and visuospatial tests). Two psychological questionnaires for depression and anxiety (BDI; STAI/Y) were also administered to patients. Pearson's correlation coefficient was used to assess the degree of association between cognitive and psychological measures. Results: Depression assessment negatively correlated with the ECAS, more significantly with regard to the executive functions subdomain. In particular, Sentence Completion and Social Cognition subscores were negatively associated with depression levels measured by BDI total score and Somatic-Performance symptoms subscore. Conversely, no significant correlations were observed between depression level and cognitive functions as measured by traditional screening tools for frontal abilities (FAB) and global cognition (MoCA) assessment. Finally, no significant correlations were observed between state/trait anxiety and the ECAS. Discussion and conclusion: This represents the first study focusing on the relationship between cognitive and psychological components in pALS by means of the ECAS, the current gold standard for ALS cognitive-behavioral assessment. If confirmed by further investigations, the observed association between depression and executive functions suggests the need for a careful screening and treatment of depression, to avoid overestimation of cognitive involvement and possibly improve cognitive performances in ALS.
Keywords: ECAS; amyotrophic lateral sclerosis; anxiety; depression; executive functions; social cognition.
Similar articles
-
Arabic adaptation of the Edinburgh cognitive and behavioural Amyotrophic lateral sclerosis screen (ECAS-AR).Rev Neurol (Paris). 2022 Oct;178(8):817-825. doi: 10.1016/j.neurol.2021.12.015. Epub 2022 May 13. Rev Neurol (Paris). 2022. PMID: 35570063
-
Edinburgh Cognitive and Behavioural ALS Screen (ECAS)-Italian version: regression based norms and equivalent scores.Neurol Sci. 2017 Jun;38(6):1059-1068. doi: 10.1007/s10072-017-2919-4. Epub 2017 Mar 22. Neurol Sci. 2017. PMID: 28332040
-
Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS).Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):387-395. doi: 10.1080/21678421.2018.1473443. Epub 2018 May 26. Amyotroph Lateral Scler Frontotemporal Degener. 2018. PMID: 29804470
-
Egyptian adaptation and validation of the Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS-EG).Neurol Sci. 2023 Jun;44(6):1871-1880. doi: 10.1007/s10072-023-06639-6. Epub 2023 Feb 8. Neurol Sci. 2023. PMID: 36753012 Free PMC article. Review.
-
Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods.Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):1-11. doi: 10.1080/21678421.2018.1530264. Epub 2018 Dec 26. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 30585510
Cited by
-
Blink Reflex Examination in Patients with Amyotrophic Lateral Sclerosis Compared to Diseases Affecting the Peripheral Nervous System and Healthy Controls.Brain Sci. 2023 Sep 28;13(10):1384. doi: 10.3390/brainsci13101384. Brain Sci. 2023. PMID: 37891753 Free PMC article.
-
The Impact of Microbiota on the Pathogenesis of Amyotrophic Lateral Sclerosis and the Possible Benefits of Polyphenols. An Overview.Metabolites. 2021 Feb 20;11(2):120. doi: 10.3390/metabo11020120. Metabolites. 2021. PMID: 33672485 Free PMC article. Review.
-
Prevalence and motor-functional correlates of frontotemporal-spectrum disorders in a large cohort of non-demented ALS patients.J Neurol. 2024 Oct;271(10):6944-6955. doi: 10.1007/s00415-024-12658-w. Epub 2024 Sep 5. J Neurol. 2024. PMID: 39235524
-
The Impact of Cognitive and Behavioral Symptoms on ALS Patients and Their Caregivers.Front Neurol. 2019 Mar 11;10:192. doi: 10.3389/fneur.2019.00192. eCollection 2019. Front Neurol. 2019. PMID: 30915018 Free PMC article. Review.
-
Correlation of single-fiber electromyography studies and functional status in patients with amyotrophic lateral sclerosis.Open Med (Wars). 2024 Jun 29;19(1):20240990. doi: 10.1515/med-2024-0990. eCollection 2024. Open Med (Wars). 2024. PMID: 38953009 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous